Mutuum Finance (MUTM) Strengthens Security Framework with CertiK Review and Active Halborn Audit GlobeNewswire December 18, 2025 DUBAI, United Arab Emirates, Dec. 18, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM), a new crypto project in the decentralized finance sector, has reported progress on multiple fronts as it prepares for its next development milestones. The project […]

Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets GlobeNewswire December 18, 2025 VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) (“Hydreight” or the “Company“), a leading provider of compliant digital health infrastructure and on-demand healthcare services across the United States, is pleased

Anfield Energy Announces Agreement to Acquire BRS Engineering, Bolstering In-House Technical Expertise for Uranium and Vanadium Projects GlobeNewswire December 18, 2025 VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Anfield Energy Inc. (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce that it has signed a definitive stock purchase

Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination GlobeNewswire December 18, 2025 The combination of denifanstat and resmetirom was generally well-tolerated Pharmacokinetic (PK) results support further development of the combination A Phase 2 trial of a denifanstat/resmetirom combination in F4 MASH patients is planned to initiate

Talisker Provides Update on Staff Reduction at Bralorne due to Atmospheric River Event in Southern British Columbia GlobeNewswire December 18, 2025 TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company“) (TSX: TSK, OTCQX: TSKFF) announces that further to the Company's news release of December 17, 2025, the Company has successfully

Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ(TM) Trial in Idiopathic Hypersomnia GlobeNewswire December 18, 2025 – Data expected in Q2 2026 – DUBLIN, Dec. 18, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced the completion of patient enrollment in REVITALYZ,

Nasdaq Maintains Over a Decade of Listings Leadership in 2025 GlobeNewswire December 18, 2025 Largest Exchange Transfer in History & Biggest IPO of the Year Highest Capital Raised Since 2021 – $46.65 Billion Raised NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) announced today that in 2025 it raised a total of

Lifecore Biomedical to be Added to Nasdaq Biotech Index GlobeNewswire December 18, 2025 CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the company's stock is expected to be added to

Celebrate the season island-style: King's Hawaiian hosts holiday happy hour pop-up in Toronto The limited-time pop-up at Lulu Bar at The Well features complimentary King's Hawaiian samples, a full menu integration of sweet and savoury dishes, and a chance to win a trip to Hawaii. GlobeNewswire December 18, 2025 Toronto, Ontario, Dec. 18, 2025 (GLOBE

Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 18, 2025 BOSTON and SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological and